openPR Logo
Press release

Dipyridamole Market: Growth, Demand, Supply, SWOT, Consumption, ROI to 2024

Dipyridamole Market: Growth, Demand, Supply, SWOT,

Global Dipyridamole Market: Overview

Dipyridamole is a yellow, odorless, and bitter-tasting crystalline powder. Dipyridamole is an oral antiplatelet drug. It is soluble in dilute acids, chloroform, and methanol but does not dissolve in water. Dipyridamole is a drug used in combination with blood thinners such as warfarin or aspirin to prevent the formation of clots after the replacement of the heart valve. Clots are a serious medical complication which could cause heart attacks, strokes, or blocking of blood vessels in the lungs. Dipyridamole is an anti-platelet drug which maintains a constant blood flow by stopping platelets from forming a clump and keeping the blood vessels open. Dipyridamole is used to treat and prevent myocardial reinfarction, blood clots in the brain, obstruction of blood vessels by blood clots, and transient ischemic attacks. Side effects of this drug include dizziness, stomach upsets, diarrhea, vomiting, headaches, and flushing.

Browse Market Research Report: http://www.transparencymarketresearch.com/dipyridamole-market.html

Dipyridamole tablets are platelet inhibitors. Each tablet contains 25 mg, 50 mg, or 75 mg of dipyridamole. Inactive ingredients present in these tablets include colloidal silicon dioxide, hypromellose, lactose monohydrate, polyethylene glycol, sodium starch glycolate, pregelatinized starch, povidone, magnesium stearate, talc, and titanium oxide. Dipyridamole increases the power of prostacyclin by preventing the phosphodiesterase enzyme activity which increases the intracellular cAMP levels. It inhibits the cellular uptake of adenosine which acts on coronary vessels and is used to evaluate coronary artery diseases in patients who cannot exercise satisfactorily and increase the blood flow to their hearts, simulating exercise.

Dipyridamole exhibits several side-effects on reacting with other medicines such as theophylline, adenosine, and anticholinesterases, which may decrease its effectiveness. There are several precautions that need to be followed while consuming the dipyridamole tablet, especially in cases of low blood pressure, drug allergies, while taking aspirin or vitamin doses, and in pregnancy. It could cause severe allergic reactions such as itching, difficulty in breathing, swelling of the mouth, tightness in the chest, swelling of the face, swelling of the lips or tongue, irregular or slow heartbeats, weakness, and chest pain. One of the adverse effect of using dipyridamole is that it increases the risk of bleeding, so in order to stop the bleeding it is taken in combination with aspirin. Dipyridamole tablets should be used cautiously by patients with hypotension as they can produce peripheral vasodilation. Dipyridamole is available on special cases for the patients who have prosthetic heart valves after coronary artery bypass surgery (CABG).

Get accurate market forecast and analysis on the Dipyridamole market. Request a sample to stay abreast on the key trends impacting this market @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22253

North America and Europe are dominant in terms of drug production, and the dipyridamole market in these regions are predicted to develop vastly. According to a survey conducted by the national institute of health, Americans are at a severe risk of suffering from strokes over the forecast period. Therefore, a pharmaceutical company recently launched an aspirin/extended-release dipyridamole which is projected to reduce the risk of heart attacks. The consumption of this drug in Asia Pacific is also prominent, especially in China and India, in terms of registered diseases on a year-on-year basis. The rest of the world accounts for a minor share in the dipyridamole market; however, the market is anticipated to develop widely in the next few years.

Key players operating in dipyridamole market are Teva Pharmaceuticals Industries Ltd, Taj Pharmaceuticals Limited, Boehringer Ingelheim Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd., and Global Pharmaceuticals.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
Visit Blog : http://cmfeglobalreports.blogspot.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dipyridamole Market: Growth, Demand, Supply, SWOT, Consumption, ROI to 2024 here

News-ID: 619762 • Views:

More Releases from Transparecny Market Research

HAZMAT Packaging Market Share, Trends, Growth, Forecast By 2027
HAZMAT Packaging Market Share, Trends, Growth, Forecast By 2027
The global HAZMAT Packaging Market is estimated to flourish at a CAGR of 5.8% from 2024 to 2027. The overall HAZMAT Packaging industry delivers an in-depth systematic framework and competitive outlook of the HAZMAT Packaging Market from a worldwide perspective. The report starts with a summary of the market, chain structure, and the past as well as current market size. Also, the growth opportunities prevalent in the market in the coming
Push Pull Closures Market Will Generate New Growth Opportunities by 2027 with Top Key Players - Closure Systems International, Inc., O. Berk Company, LLC, Silgan Plastic Closures Solutions
Push Pull Closures Market Will Generate New Growth Opportunities by 2027 with To …
The global Push Pull Closures Market is estimated to flourish at a CAGR of 4.8% from 2024 to 2027. The overall Push Pull Closures industry delivers an in-depth systematic framework and competitive outlook of the Push Pull Closures Market from a worldwide perspective. The report starts with a summary of the market, chain structure, and the past as well as current market size. Also, the growth opportunities prevalent in the market
PET Preform Machines Market Estimated to Touch USD 14.1 billion at a CAGR of 6.0% by 2031
PET Preform Machines Market Estimated to Touch USD 14.1 billion at a CAGR of 6.0 …
The global PET Preform Machines Market has been sailing through robust waters, witnessing a valuation of US$ 8.3 Bn 2022. As we set our sights on the horizon, the market is poised to embark on a journey of steady growth, with a projected Compound Annual Growth Rate (CAGR) of 6.0% from 2023 to 2031. By the end of 2031, the industry is expected to anchor at an impressive US$ 14.1
Flexible Packaging Paper Market Share, Trends, Growth, Forecast By 2029
Flexible Packaging Paper Market Share, Trends, Growth, Forecast By 2029
The global Flexible Packaging Paper Market has been sailing through robust waters, witnessing a valuation of US$ 47.5 Bn 2021. As we set our sights on the horizon, the market is poised to embark on a journey of steady growth, with a projected Compound Annual Growth Rate (CAGR) of 4.1% from 2023 to 2029. By the end of 2029, the industry is expected to anchor at an impressive US$ 65.2

All 5 Releases


More Releases for Dipyridamole

Dipyridamole Market Key Players And Growth Analysis With Forecast | 2024
Dipyridamole is a yellow, odorless, and bitter-tasting crystalline powder. Dipyridamole is an oral antiplatelet drug. It is soluble in dilute acids, chloroform, and methanol but does not dissolve in water. Dipyridamole is a drug used in combination with blood thinners such as warfarin or aspirin to prevent the formation of clots after the replacement of the heart valve. Clots are a serious medical complication which could cause heart attacks, strokes,
Pharmacologic Stress Agents Market to Reflect Impressive Growth Rate During 2016 …
Pharmacologic stress agents are employed in pharmacologic stress testing such as cardiovascular stress test, which is used along with well-known imaging modalities such as echocardiography (ECG) and radionuclide imaging tests. Cardiovascular stress test is an advanced version of exercise testing using treadmill bicycle exercise in coordination with blood pressure monitoring and ECG. The pharmacologic stress agent and nuclear tracer are injected through intravenous (IV) line while the heart rate, blood
Dipyridamole Market By Manufacturers, Type, Applications, Forecast 2024
Dipyridamole is a yellow, odorless, and bitter-tasting crystalline powder. Dipyridamole is an oral antiplatelet drug. It is soluble in dilute acids, chloroform, and methanol but does not dissolve in water. Dipyridamole is a drug used in combination with blood thinners such as warfarin or aspirin to prevent the formation of clots after the replacement of the heart valve. Clots are a serious medical complication which could cause heart attacks, strokes,
Dipyridamole Market : Structure and Overview of Key Market Forces Propelling Mar …
Dipyridamole is a yellow, odorless, and bitter-tasting crystalline powder. Dipyridamole is an oral antiplatelet drug. It is soluble in dilute acids, chloroform, and methanol but does not dissolve in water. Dipyridamole is a drug used in combination with blood thinners such as warfarin or aspirin to prevent the formation of clots after the replacement of the heart valve. Clots are a serious medical complication which could cause heart attacks, strokes,
Dipyridamole Market share will expand till 2024
A new research report by Transparency Market Research offers a comprehensive evaluation of the global Dipyridamole Market. The study, titled “Dipyridamole Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024”, is available for sale on the firm’s website. Dipyridamole is a yellow, odorless, and bitter-tasting crystalline powder. Dipyridamole is an oral antiplatelet drug. It is soluble in dilute acids, chloroform, and methanol but does not dissolve
Dipyridamole Market Evolving Industry Trends 2024
Dipyridamole is a yellow, odorless, and bitter-tasting crystalline powder. Dipyridamole is an oral antiplatelet drug. It is soluble in dilute acids, chloroform, and methanol but does not dissolve in water. Dipyridamole is a drug used in combination with blood thinners such as warfarin or aspirin to prevent the formation of clots after the replacement of the heart valve. Clots are a serious medical complication which could cause heart attacks, strokes,